The Interaction between the Gut Microbiome and Bile Acids in Cardiometabolic Diseases
Cardio-metabolic diseases (CMD) are a spectrum of diseases (e.g., type 2 diabetes, atherosclerosis, non-alcohol fatty liver disease (NAFLD), and metabolic syndrome) that are among the leading causes of morbidity and mortality worldwide. It has long been known that bile acids (BA), which are endogeno...
Main Authors: | Cengiz Callender, Ilias Attaye, Max Nieuwdorp |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/12/1/65 |
Similar Items
-
Effects of Prevotella copri on insulin, gut microbiota and bile acids
by: Jiatai Gong, et al.
Published: (2024-12-01) -
Examining the Interaction of the Gut Microbiome with Host Metabolism and Cardiometabolic Health in Metabolic Syndrome
by: Serena Galié, et al.
Published: (2021-11-01) -
Physiological Role of Bile Acids Modified by the Gut Microbiome
by: Yoshimitsu Kiriyama, et al.
Published: (2021-12-01) -
Elevated gut microbiota metabolite bile acids confer protective effects on clinical prognosis in ischemic stroke patients
by: Zhaobin Wang, et al.
Published: (2024-04-01) -
Bile Acids: Major Regulator of the Gut Microbiome
by: Chihyeok An, et al.
Published: (2022-09-01)